PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications

The new immunotherapy targeting the programmed cell death 1 (PD-1) receptor and its cognate ligand PD-L1 has renewed hopes of eradicating the most difficult human cancers to treat. Among these, there are the poorly differentiated and anaplastic thyroid cancers, unresponsive to all the therapies curr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Mol Sci
Glavni autori: Ulisse, Salvatore, Tuccilli, Chiara, Sorrenti, Salvatore, Antonelli, Alessandro, Fallahi, Poupak, D’Armiento, Eleonora, Catania, Antonio, Tartaglia, Francesco, Amabile, Maria Ida, Giacomelli, Laura, Metere, Alessio, Cornacchini, Nicola, Pironi, Daniele, Carbotta, Giovanni, Vergine, Massimo, Monti, Massimo, Baldini, Enke
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2019
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6471477/
https://ncbi.nlm.nih.gov/pubmed/30897754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20061405
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items